SCHEMBL14860992

SCHEMBL14860992

O=C1NC(=S)C(=Cc2ccncc2)S1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 13/20 1.00
▸ CISD1 Q9NZ45 4/20 0.70
▸ MAOA P21397 2/20 0.70
▸ GSK3B P49841 1/20 0.70
▸ PNP P00491 2/20 0.66
▸ MEN1 O00255 2/20 0.56
▸ ALDH1A1 P00352 2/20 0.56
▸ LMNA P02545 2/20 0.56
▸ MAPT P10636 2/20 0.56
▸ HPGD P15428 2/20 0.56
▸ KMT2A Q03164 2/20 0.56
▸ POLB P06746 1/20 0.56
▸ MAPK1 P28482 1/20 0.56
▸ RAB9A P51151 1/20 0.56
▸ SMN1; SMN2 Q16637 1/20 0.56
▸ RECQL P46063 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14860989 1.00 TDP1 (1.00) TDP1CISD1MAOAGSK3BPNP
SCHEMBL14860991 1.00 TDP1 (1.00) TDP1CISD1MAOAGSK3BPNP
SCHEMBL14860976 0.83 TDP1 (1.00) TDP1GSK3BPNPMEN1ALDH1A1
SCHEMBL14860974 0.83 TDP1 (1.00) TDP1GSK3BPNPMEN1ALDH1A1
SCHEMBL14860978 0.83 TDP1 (1.00) TDP1GSK3BPNPMEN1ALDH1A1
SCHEMBL1249998 0.82 CISD1 (1.00) TDP1CISD1MAOAGSK3BHPGD
SCHEMBL2424616 0.82 CISD1 (1.00) TDP1CISD1MAOAGSK3BHPGD
SCHEMBL19546477 0.82 TDP1 (0.70) TDP1PNP
SCHEMBL2685789 0.82 TDP1 (0.70) TDP1PNP
SCHEMBL2685792 0.82 TDP1 (0.70) TDP1PNP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013055771-A1 THIOXOTHIAZOLIDINONE DERIVATIVES USEFUL AS INHIBITORS OF TDP1 THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2013-04-18 — — WO disclosed
Send feedback